Last update 31 May 2025

SynOV1.1

Overview

Basic Info

Drug Type
Oncolytic virus
Synonyms
SYNOV1.1
Target
CSF-2R
Action
stimulants
Mechanism
CSF-2R stimulants(Granulocyte-macrophage colony-stimulating factor receptor stimulants), Immunostimulants
Therapeutic Areas
NeoplasmsDigestive System Disorders
Active Indication
Advanced Malignant Solid NeoplasmStomach Cancer
Inactive Indication
Hepatocellular Carcinoma
Originator Organization
Beijing SyngenTech Co., Ltd.Beijing SyngenTech Co., Ltd.
Active Organization
Beijing SyngenTech Co., Ltd.Beijing SyngenTech Co., Ltd.
Inactive Organization-
License Organization-
Drug Highest PhasePhase 1
First Approval Date-
Regulation-
Login to view timeline

Related

2
Clinical Trials associated with SynOV1.1
NCT04612504
/ Unknown statusPhase 1
An Open-label Phase I Study to Evaluate the Safety, Tolerability and Efficacy of SynOV1.1 Recombinant Oncolytic Adenovirus Injection as Monotherapy in Participants With Locally Advanced or Metastatic Solid Tumors
ChiCTR2200059849
/ SuspendedEarly Phase 1IIT
Single-arm, open-label, dose-escalation study of SynOV1.1 adenovirus injection combined with anti-PD-1 antibodies in advanced HCC patients
100 Clinical Results associated with SynOV1.1
Login to view more data
100 Translational Medicine associated with SynOV1.1
Login to view more data
100 Patents (Medical) associated with SynOV1.1
Login to view more data
100 Deals associated with SynOV1.1
Login to view more data

R&D Status

10 top R&D records.
Login
to view more data
IndicationHighest PhaseCountry/LocationOrganizationDate
Advanced Malignant Solid NeoplasmPhase 1
China
Beijing SyngenTech Co., Ltd.Beijing SyngenTech Co., Ltd.
28 Jul 2022
Hepatocellular CarcinomaPhase 1
China
Beijing SyngenTech Co., Ltd.Beijing SyngenTech Co., Ltd.
23 Jun 2022
Stomach CancerPhase 1
China
Beijing SyngenTech Co., Ltd.Beijing SyngenTech Co., Ltd.
30 Jan 2022
Login to view more data

Clinical Result

Indication
Phase
Evaluation
View All Results
Study
Phase
PopulationAnalyzed EnrollmentGroupResultsEvaluationPublication Date

No Data

Login to view more data

Translational Medicine

Boost your research with our translational medicine data.
login
or
view full example data
Boost your research with our translational medicine data.

Deal

Boost your decision using our deal data.
login
or
view full example data
Boost your decision using our deal data.

Core Patent

Boost your research with our Core Patent data.
login
or
view full example data
Boost your research with our Core Patent data.

Clinical Trial

Identify the latest clinical trials across global registries.
login
or
view full example data
Identify the latest clinical trials across global registries.

Approval

Accelerate your research with the latest regulatory approval information.
login
or
view full example data
Accelerate your research with the latest regulatory approval information.

Regulation

Understand key drug designations in just a few clicks with Synapse.
login
or
view full example data
Understand key drug designations in just a few clicks with Synapse.
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free